From chronic pruritus to neuroendocrine tumor: A case report (original) (raw)
2022, Experimental and Therapeutic Medicine
Chronic pruritus is a major and distressing symptom of many diseases of dermatological, neurological, psychogenic or systemic origin. This chronic itch could be a presenting sign of malignancy; therefore, paraneoplastic pruritus has also been associated with neuroendocrine tumors (NETs). This article focuses on a patient presenting with chronic pruritus for the past 12 months and who received numerous treatment schemes with very poor clinical improvement, that presented in the hospital for worsening of the chronic pruritus associated with skin rash and significant weight loss (approximately 6 kg over a 2-month period). The laboratory tests showed iron deficiency anemia, eosinophilia and negative tumor markers. In order to investigate the hypoanabolic and anemic syndromes, upper gastrointestinal endoscopy and colonoscopy, which showed no lesions or tumors, were employed. Skin biopsy was performed and antihistaminic and local steroid treatment was initiated. The patient's status worsened within a week and the patient was started on systemic steroid treatment with poor results. Computer tomography was performed to identify any tumor(s) located either in the pelvis or abdomen. A lesion was found in the terminal ileum, identified as a hypervascularized associating bulky lymphadenopathy. The patient was transferred to the surgical ward where right hemicolectomy with manual ileotransverse anastomosis L-L was performed. The histopathological result confirmed NET G2. The patient clinically improved, the skin lesions resolved and the itchiness disappeared. The general status improved significantly. NET G2 diagnosing was possible due to the atypic paraneoplastic sign: chronic pruritus. This case study highlights the association between itch and malignancy and presents an atypical way of NET presentation when all tumor markers remain negative.
Sign up for access to the world's latest research.
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
Related papers
Cutaneous Prurigo-Case Presentation
We present the case of a patient of 76 years old with chronic cutaneous pruritus, who was admitted to the department of Allergology to investigate its etiology. The patient has permanent pacemaker for third-degree atrioventricular block and multiple associated cardiac conditions, chronic kidney disease stage IV. After multiple investigations, the patient was diagnosed with stage IV lung cancer, the recommendation consisted of the symptomatic therapy only. Lung cancer is one of the rare cases that can cause chronic itching. Cuvinte cheie: prurigo, cancer pulmonary, pulmonary cancer, boala renala cronica Rezumat: Prezentăm cazul unui pacient de 76 ani cu prurit cutanat cronic care a fost internat în compartimentul de Alergologie pentru investigarea etiologiei acestuia. Pacientul este cu cardiostimulare permanentă pentru bloc atrio-ventricular gradul III şi multiple afecţiuni cardiace asociate, boală renală cronică stadiul IV. După multiple investigaţii, pacientul a fost diagnosticat cu neoplasm pulmonar stadiul IV, cu recomandare doar de terapie simptomatică. Neoplasmul pulmonar este una dintre cauzele rare care pot genera prurit cronic.
Acute onset of generalised pruritus as presenting symptom of Klatskin tumour
Case Reports, 2012
A 60-year-old Korean woman presented with generalised pruritus and abdominal pain. She was initially treated with oral antihistamine therapy, but upon progression of symptoms and jaundice involvement, she was found to have a Klatskin tumour. The patient was not a candidate for surgical resection and is currently undergoing palliative care.
Paraneoplastic pruritus presenting with Hodgkin’s lymphoma: a case report
Journal of Medical Case Reports, 2014
Introduction: Paraneoplastic pruritus is defined as pruritus that occurs before or during the natural evolution of a hematologic disease. The reported prevalence is 30% in patients with Hodgkin's lymphoma. The severity of this pruritus has a very negative impact on patients' quality of life. Very few studies have been made to examine the efficacy of pharmacological treatments for this type of pruritus. One drug that appears to be effective in this respect is off-label aprepitant, a neurokinin 1 receptor antagonist. Case presentation: A 20-year-old Caucasian woman presented with lateral neck nodes, sweating, and pruritus and was diagnosed with stage IIB nodular sclerosis Hodgkin's lymphoma. Throughout this period during the disease the pruritus was ever-present. Improvement was achieved with some of the chemotherapy treatments, but the symptom returned when the various treatments were withdrawn due to disease progression or poor tolerance. In the middle of the seventh year, she was admitted to our hospital with uncontrolled pruritus that resulted in severe lesions due to scratching. In response, aprepitant (off-label) 80mg/day was added to the chemotherapic treatment of the pruritus, after studying the various treatment options. She reported a score of 9 on a visual analogue scale for the pruritus, and a score of 3 on the Eastern Cooperative Oncology Group performance status scale of performance status. After two weeks of treatment with aprepitant, she reported a score of 5 on the visual analogue scale for the pruritus, and this improved to a score of 4 in a month, which allowed her to lead a better quality of life, with an Eastern Cooperative Oncology Group performance status score between 1 and 2. Conclusions: Several cases and case series have been reported on the use of aprepitant for paraneoplastic pruritus, but none have referred to its use for Hodgkin's lymphoma. A prospective study was carried out to evaluate the efficacy of this drug in refractory pruritus secondary to Sezary syndrome, and other authors have studied the effectiveness of aprepitant against pruritus, secondary to biological therapy with erlotinib. In our case report, treatment was started with daily doses of aprepitant 80mg. Pruritus improvement appeared to be attributable exclusively to the administration of aprepitant.
Cutaneous manifestations of underlying malignancies presenting to a tertiary care teaching hospital
International Journal of Research in Dermatology, 2019
Background: The skin is the largest organ in the human body. Many types of cancers can cause lesions to appear on the skin. An association between systemic malignancy and cutaneous manifestations has long been recognized. Recognition of these lesions is important for diagnosis at early stages and hence we analyzed the presentation of various skin manifestations in relation to various malignancies. Methods: We did a prospective study from June 2016 to November 2017 on 50 confirmed cases of internal malignancy with skin manifestations attending the DVL and Oncology OPD of NRI Medical College and General Hospital and Cancer Institute. Detailed history, cutaneous examination, and investigations were done. Results: Study population included 23 males and 27 females. The majority of cases (34%) were aged above 60 years. In females, reproductive tract malignancies were the highest (37%). In males, Non-Hodgkin's lymphoma (17.3%) and carcinoma rectum (17.3%) were commonly seen. Generalized pruritus was the major presenting cutaneous manifestation (16.4%). Paraneoplastic dermatoses were the most frequent cutaneous markers (67.2%). Conclusions: Cutaneous manifestation from an internal malignancy is a relatively uncommon phenomenon. But at times, they may be the only presenting feature. Cutaneous paraneoplastic syndromes are important clinical markers that may precede or occur simultaneously or after the diagnosis of a given neoplasm and recognizing them may lead to a higher chance of cure and better prognosis for the patient.
Chronic Pruritus in the Absence of Specific Skin Disease
American Journal of Clinical Dermatology, 2010
Chronic pruritus is a major and distressing symptom of many cutaneous and systemic diseases and can significantly impair the patient's quality of life. Pruritus perception is the final result of a complex network involving dedicated nerve pathways and brain areas, and an increasing number of peripheral and central mediators are thought to be involved. Itch is associated with most cutaneous disorders and, in these circumstances, its management overlaps with that of the skin disease. Itch can also occur without associated skin diseases or primary skin lesions, but only with nonspecific lesions secondary to rubbing or scratching. Chronic itch with no or minimal skin changes can be secondary to important diseases, such as neurologic disorders, chronic renal failure, cholestasis, systemic infections, malignancies, and endocrine disorders, and may also result from exposure to some drugs. The search for the cause of pruritus usually requires a meticulous step-by-step assessment involving careful history taking as well as clinical examination and laboratory investigations.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.